In the last 12 months, insiders at Alector, Inc. ($ALEC) filed 149 transactions with the SEC: 0 open-market purchases totaling $0 and 63 sales totaling $9,153,334. Net insider sentiment: net selling.
Alector, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Polaris Venture Management Co. VI, L.L.C. (TenPercentOwner) — 4 transactions totaling $3,000,000
- MCGUIRE TERRANCE (Director) — 6 transactions totaling $3,000,000
- Rosenthal Arnon (Chief Executive Officer) — 23 transactions totaling $1,401,302
- Kenkare-Mitra Sara (President and Head of R&D) — 17 transactions totaling $663,183
- Romano Gary (Chief Medical Officer) — 13 transactions totaling $289,034
View all SEC Filings for Alector, Inc. (ALEC).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | Rosenthal Arnon | Chief Executive Officer | A | Common Stock | 116246 | $0.00 | 6,384,797.0000 | 109,151,472 | 1.85% | 0.11% |
| March 15, 2026 | Berkley Neil Lindsay | CFO & Chief Business Officer | A | Common Stock | 54600 | $0.00 | 399,260.0000 | 109,151,472 | 15.84% | 0.05% |
| March 10, 2026 | Wong-Sarad Grace | Principal Accounting Officer | S | Common Stock | 1000 | $2.65 | 106,465.0000 | 109,151,472 | 0.93% | 0.00% |
| March 2, 2026 | Wong-Sarad Grace | Principal Accounting Officer | S | Common Stock | 8071 | $2.12 | 110,832.0000 | 109,151,472 | 6.79% | 0.01% |
| March 2, 2026 | Rosenthal Arnon | Chief Executive Officer | S | Common Stock | 81864 | $2.12 | 6,268,551.0000 | 109,151,472 | 1.29% | 0.08% |
| March 2, 2026 | Berkley Neil Lindsay | CFO & Chief Business Officer | S | Common Stock | 29649 | $2.12 | 344,660.0000 | 109,151,472 | 7.92% | 0.03% |
| March 3, 2026 | Wong-Sarad Grace | Principal Accounting Officer | S | Common Stock | 3367 | $2.08 | 107,465.0000 | 109,151,472 | 3.04% | 0.00% |
| Feb. 26, 2026 | Wong-Sarad Grace | Principal Accounting Officer | S | Common Stock | 4079 | $2.50 | 118,903.0000 | 109,151,472 | 3.32% | 0.00% |
| Dec. 5, 2025 | Wong-Sarad Grace | Principal Accounting Officer | S | Common Stock | 4753 | $1.21 | 122,982.0000 | 109,151,472 | 3.72% | 0.00% |
| Dec. 3, 2025 | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 41687 | $1.12 | 501,652.0000 | 109,151,472 | 7.67% | 0.04% |
| Dec. 3, 2025 | Berkley Neil Lindsay | Chief Bus Ofcr & Interim CFO | S | Common Stock | 37261 | $1.12 | 374,309.0000 | 109,151,472 | 9.05% | 0.03% |
| Dec. 3, 2025 | Wong-Sarad Grace | Principal Accounting Officer | S | Common Stock | 8056 | $1.12 | 127,735.0000 | 109,151,472 | 5.93% | 0.01% |
| Dec. 3, 2025 | Rosenthal Arnon | Chief Executive Officer | S | Common Stock | 104347 | $1.12 | 6,350,415.0000 | 109,151,472 | 1.62% | 0.10% |
| Nov. 10, 2025 | Berkley Neil Lindsay | Chief Bus Ofcr & Interim CFO | A | Common Stock | 65000 | $0.00 | 411,570.0000 | 109,151,472 | 18.76% | 0.06% |
| Nov. 10, 2025 | Rosenthal Arnon | Chief Executive Officer | A | Employee Stock Option (right to buy) | 522500 | $0.00 | 522,500.0000 | 109,151,472 | 9999.99% | 0.48% |
| Nov. 10, 2025 | Rosenthal Arnon | Chief Executive Officer | A | Common Stock | 174167 | $0.00 | 6,454,762.0000 | 109,151,472 | 2.77% | 0.16% |
| Nov. 10, 2025 | Wong-Sarad Grace | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 48535 | $0.00 | 48,535.0000 | 109,151,472 | 9999.99% | 0.04% |
| Nov. 10, 2025 | Wong-Sarad Grace | Principal Accounting Officer | A | Common Stock | 32343 | $0.00 | 135,791.0000 | 109,151,472 | 31.26% | 0.03% |
| Nov. 10, 2025 | Berkley Neil Lindsay | Chief Bus Ofcr & Interim CFO | A | Employee Stock Option (right to buy) | 195000 | $0.00 | 195,000.0000 | 109,151,472 | 9999.99% | 0.18% |
| Sept. 2, 2025 | Rosenthal Arnon | Chief Executive Officer | S | Common Stock | 51562 | $2.50 | 6,280,595.0000 | 99,085,888 | 0.81% | 0.05% |
| Sept. 2, 2025 | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 23638 | $2.50 | 543,339.0000 | 99,085,888 | 4.17% | 0.02% |
| Sept. 2, 2025 | Berkley Neil Lindsay | Principal Financial Officer | S | Common Stock | 15842 | $2.50 | 346,570.0000 | 99,085,888 | 4.37% | 0.02% |
| Sept. 2, 2025 | Wong-Sarad Grace | Principal Accounting Officer | S | Common Stock | 5910 | $2.50 | 103,448.0000 | 99,085,888 | 5.40% | 0.01% |
| Aug. 26, 2025 | Hammond Paula | Not found | S | Common Stock | 14000 | $2.36 | 74,909.0000 | 99,085,888 | 15.75% | 0.01% |
| July 1, 2025 | Kenkare-Mitra Sara | President and Head of R&D | A | Employee Stock Option (right to buy) | 18250 | $0.00 | 18,250.0000 | 99,085,888 | 9999.99% | 0.02% |
| July 1, 2025 | Rosenthal Arnon | Chief Executive Officer | A | Employee Stock Option (right to buy) | 45700 | $0.00 | 45,700.0000 | 99,085,888 | 9999.99% | 0.05% |
| July 1, 2025 | Rosenthal Arnon | Chief Executive Officer | A | Common Stock | 137125 | $0.00 | 6,482,157.0000 | 99,085,888 | 2.16% | 0.14% |
| July 1, 2025 | Kenkare-Mitra Sara | President and Head of R&D | A | Common Stock | 54725 | $0.00 | 566,977.0000 | 99,085,888 | 10.68% | 0.06% |
| July 1, 2025 | Berkley Neil Lindsay | Principal Financial Officer | A | Employee Stock Option (right to buy) | 18000 | $0.00 | 18,000.0000 | 99,085,888 | 9999.99% | 0.02% |
| June 20, 2025 | Yaffe Kristine | Not found | S | Common Stock | 1000 | $1.44 | 95,409.0000 | 99,085,888 | 1.04% | 0.00% |
| June 11, 2025 | Altmeyer Mark | Not found | A | Common Stock | 28700 | $0.00 | 69,950.0000 | 99,085,888 | 69.58% | 0.03% |
| June 11, 2025 | Hammond Paula | Not found | A | Common Stock | 28700 | $0.00 | 88,909.0000 | 99,085,888 | 47.67% | 0.03% |
| June 11, 2025 | Hammond Paula | Not found | A | Stock Option (right to buy) | 9450 | $0.00 | 9,450.0000 | 99,085,888 | 9999.99% | 0.01% |
| June 11, 2025 | Yaffe Kristine | Not found | A | Common Stock | 28700 | $0.00 | 96,409.0000 | 99,085,888 | 42.39% | 0.03% |
| June 11, 2025 | Yaffe Kristine | Not found | A | Stock Option (right to buy) | 9450 | $0.00 | 9,450.0000 | 99,085,888 | 9999.99% | 0.01% |
| June 11, 2025 | GAROFALO ELIZABETH A. | Not found | A | Common Stock | 28700 | $0.00 | 89,950.0000 | 99,085,888 | 46.86% | 0.03% |
| June 11, 2025 | GAROFALO ELIZABETH A. | Not found | A | Stock Option (right to buy) | 9450 | $0.00 | 9,450.0000 | 99,085,888 | 9999.99% | 0.01% |
| June 11, 2025 | SCHELLER RICHARD H | Not found | A | Common Stock | 28700 | $0.00 | 95,366.0000 | 99,085,888 | 43.05% | 0.03% |
| June 11, 2025 | SCHELLER RICHARD H | Not found | A | Stock Option (right to buy) | 9450 | $0.00 | 9,450.0000 | 99,085,888 | 9999.99% | 0.01% |
| June 11, 2025 | LAVIGNE LOUIS J JR | Not found | A | Common Stock | 28700 | $0.00 | 109,961.0000 | 99,085,888 | 35.32% | 0.03% |
| June 11, 2025 | LAVIGNE LOUIS J JR | Not found | A | Stock Option (right to buy) | 9450 | $0.00 | 9,450.0000 | 99,085,888 | 9999.99% | 0.01% |
| June 11, 2025 | DESOUZA ERROL B | Not found | A | Common Stock | 28700 | $0.00 | 69,950.0000 | 99,085,888 | 69.58% | 0.03% |
| June 11, 2025 | DESOUZA ERROL B | Not found | A | Stock Option (right to buy) | 9450 | $0.00 | 9,450.0000 | 99,085,888 | 9999.99% | 0.01% |
| June 11, 2025 | Altmeyer Mark | Not found | A | Stock Option (right to buy) | 9450 | $0.00 | 9,450.0000 | 99,085,888 | 9999.99% | 0.01% |
| June 2, 2025 | GRASSO MARC | Chief Financial Officer | S | Common Stock | 16488 | $1.34 | 296,072.0000 | 99,085,888 | 5.28% | 0.02% |
| June 2, 2025 | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 23890 | $1.34 | 512,252.0000 | 99,085,888 | 4.46% | 0.02% |
| June 2, 2025 | Rosenthal Arnon | Chief Executive Officer | S | Common Stock | 52087 | $1.34 | 6,345,032.0000 | 99,085,888 | 0.81% | 0.05% |
| May 2, 2025 | SCHELLER RICHARD H | Not found | A | Common Stock | 15833 | $0.00 | 66,666.0000 | 99,085,888 | 31.15% | 0.02% |
| March 3, 2025 | GRASSO MARC | Chief Financial Officer | S | Common Stock | 18091 | $1.47 | 312,560.0000 | 99,085,888 | 5.47% | 0.02% |
| March 3, 2025 | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 29073 | $1.47 | 536,142.0000 | 99,085,888 | 5.14% | 0.03% |
| March 3, 2025 | Rosenthal Arnon | Chief Executive Officer | S | Common Stock | 40330 | $1.47 | 6,397,119.0000 | 99,085,888 | 0.63% | 0.04% |
| March 3, 2025 | Romano Gary | Chief Medical Officer | S | Common Stock | 16306 | $1.47 | 332,977.0000 | 99,085,888 | 4.67% | 0.02% |
| Dec. 2, 2024 | Romano Gary | Chief Medical Officer | S | Common Stock | 14892 | $2.52 | 349,283.0000 | 0 | 4.09% | 0.00% |
| Dec. 2, 2024 | GRASSO MARC | Chief Financial Officer | S | Common Stock | 16489 | $2.52 | 330,651.0000 | 0 | 4.75% | 0.00% |
| Dec. 2, 2024 | Rosenthal Arnon | Chief Executive Officer | S | Common Stock | 52172 | $2.52 | 6,437,449.0000 | 0 | 0.80% | 0.00% |
| Dec. 2, 2024 | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 26500 | $2.52 | 565,215.0000 | 0 | 4.48% | 0.00% |
| Aug. 2, 2024 | SCHELLER RICHARD H | Not found | A | Common Stock | 15833 | $0.00 | 50,833.0000 | 0 | 45.24% | 0.00% |
| Oct. 1, 2024 | Romano Gary | Chief Medical Officer | A | Common Stock | 184380 | $0.00 | 364,175.0000 | 0 | 102.55% | 0.00% |
| Oct. 1, 2024 | Rosenthal Arnon | Chief Executive Officer | A | Common Stock | 610500 | $0.00 | 6,489,621.0000 | 0 | 10.38% | 0.00% |
| Oct. 1, 2024 | Kenkare-Mitra Sara | President and Head of R&D | A | Common Stock | 300000 | $0.00 | 591,715.0000 | 0 | 102.84% | 0.00% |
| Oct. 1, 2024 | GRASSO MARC | Chief Financial Officer | A | Common Stock | 216400 | $0.00 | 347,140.0000 | 0 | 165.52% | 0.00% |
| Sept. 3, 2024 | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 13926 | $4.88 | 291,715.0000 | 0 | 4.56% | 0.00% |
| Sept. 3, 2024 | GRASSO MARC | Chief Financial Officer | S | Common Stock | 7297 | $4.88 | 130,740.0000 | 0 | 5.29% | 0.00% |
| Sept. 3, 2024 | Rosenthal Arnon | Chief Executive Officer | S | Common Stock | 26499 | $4.88 | 5,879,121.0000 | 0 | 0.45% | 0.00% |
| Sept. 3, 2024 | Romano Gary | Chief Medical Officer | S | Common Stock | 8478 | $4.88 | 179,795.0000 | 0 | 4.50% | 0.00% |
| Aug. 22, 2024 | SCHELLER RICHARD H | Not found | S | Common Stock | 44250 | $5.16 | 35,000.0000 | 0 | 55.84% | 0.00% |
| Aug. 12, 2024 | Hammond Paula | Not found | S | Common Stock | 10500 | $5.06 | 60,209.0000 | 0 | 14.85% | 0.00% |
| Aug. 12, 2024 | Yaffe Kristine | Not found | S | Common Stock | 5000 | $5.06 | 67,709.0000 | 0 | 6.88% | 0.00% |
| June 12, 2024 | LAVIGNE LOUIS J JR | Not found | A | Common Stock | 35000 | $0.00 | 81,261.0000 | 0 | 75.66% | 0.00% |
| June 12, 2024 | SCHELLER RICHARD H | Not found | A | Common Stock | 35000 | $0.00 | 79,250.0000 | 0 | 79.10% | 0.00% |
| June 12, 2024 | GAROFALO ELIZABETH A. | Not found | A | Common Stock | 35000 | $0.00 | 61,250.0000 | 0 | 133.33% | 0.00% |
| June 12, 2024 | Yaffe Kristine | Not found | A | Common Stock | 35000 | $0.00 | 72,709.0000 | 0 | 92.82% | 0.00% |
| June 12, 2024 | Hammond Paula | Not found | A | Common Stock | 35000 | $0.00 | 70,709.0000 | 0 | 98.01% | 0.00% |
| June 12, 2024 | Wehner David M. | Not found | A | Common Stock | 35000 | $0.00 | 115,330.0000 | 0 | 43.57% | 0.00% |
| June 3, 2024 | GRASSO MARC | Chief Financial Officer | S | Common Stock | 6920 | $4.80 | 138,037.0000 | 0 | 4.77% | 0.00% |
| June 3, 2024 | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 13206 | $4.80 | 305,641.0000 | 0 | 4.14% | 0.00% |
| June 3, 2024 | Romano Gary | Chief Medical Officer | S | Common Stock | 8040 | $4.80 | 188,273.0000 | 0 | 4.10% | 0.00% |
| June 3, 2024 | Rosenthal Arnon | Chief Executive Officer | S | Common Stock | 25135 | $4.80 | 5,905,620.0000 | 0 | 0.42% | 0.00% |
| May 29, 2024 | Polaris Venture Management Co. VI, L.L.C. | Not found | J | Common Stock | 98533 | $0.00 | 9,853,817.0000 | 0 | 0.99% | 0.00% |
| May 29, 2024 | Polaris Venture Management Co. VI, L.L.C. | Not found | J | Common Stock | 500000 | $0.00 | 9,853,817.0000 | 0 | 4.83% | 0.00% |
| May 29, 2024 | Polaris Venture Management Co. VI, L.L.C. | Not found | J | Common Stock | 98533 | $0.00 | 9,952,350.0000 | 0 | 1.00% | 0.00% |
| April 30, 2024 | Polaris Venture Management Co. VI, L.L.C. | Not found | J | Common Stock | 98533 | $0.00 | 10,353,817.0000 | 0 | 0.94% | 0.00% |
| April 30, 2024 | Polaris Venture Management Co. VI, L.L.C. | Not found | J | Common Stock | 98533 | $0.00 | 10,452,350.0000 | 0 | 0.95% | 0.00% |
| April 30, 2024 | Polaris Venture Management Co. VI, L.L.C. | Not found | J | Common Stock | 500000 | $0.00 | 10,353,817.0000 | 0 | 4.61% | 0.00% |
| March 19, 2024 | Altmeyer Mark | Not found | A | Stock Option (right to buy) | 19420 | $0.00 | 19,420.0000 | 0 | 9999.99% | 0.00% |
| March 19, 2024 | DESOUZA ERROL B | Not found | A | Common Stock | 41250 | $0.00 | 41,250.0000 | 0 | 9999.99% | 0.00% |
| March 19, 2024 | DESOUZA ERROL B | Not found | A | Stock Option (right to buy) | 19420 | $0.00 | 19,420.0000 | 0 | 9999.99% | 0.00% |
| March 19, 2024 | Altmeyer Mark | Not found | A | Common Stock | 41250 | $0.00 | 41,250.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2024 | Romano Gary | Chief Medical Officer | S | Common Stock | 6001 | $6.92 | 196,313.0000 | 0 | 2.97% | 0.00% |
| March 4, 2024 | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 10169 | $6.92 | 318,847.0000 | 0 | 3.09% | 0.00% |
| March 4, 2024 | GRASSO MARC | Chief Financial Officer | S | Common Stock | 5716 | $6.92 | 144,957.0000 | 0 | 3.79% | 0.00% |
| March 4, 2024 | Rosenthal Arnon | Chief Executive Officer | S | Common Stock | 18837 | $6.92 | 5,930,755.0000 | 0 | 0.32% | 0.00% |
| July 15, 2023 | SCHELLER RICHARD H | Not found | A | Common Stock | 8541 | $0.00 | 44,250.0000 | 0 | 23.92% | 0.00% |
| Dec. 4, 2023 | Rosenthal Arnon | Chief Executive Officer | S | Common Stock | 23831 | $5.56 | 5,949,592.0000 | 0 | 0.40% | 0.00% |
| Dec. 5, 2023 | GAROFALO ELIZABETH A. | Not found | G | Common Stock | 9459 | $0.00 | 26,250.0000 | 0 | 26.49% | 0.00% |
| Dec. 4, 2023 | Romano Gary | Chief Medical Officer | S | Common Stock | 5035 | $5.56 | 202,314.0000 | 0 | 2.43% | 0.00% |
| Dec. 4, 2023 | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 12519 | $5.56 | 329,016.0000 | 0 | 3.67% | 0.00% |
| Dec. 4, 2023 | GRASSO MARC | Chief Financial Officer | S | Common Stock | 4574 | $5.56 | 150,673.0000 | 0 | 2.95% | 0.00% |
| Oct. 1, 2023 | GRASSO MARC | Chief Financial Officer | A | Employee Stock Option (right to buy) | 41000 | $0.00 | 41,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2023 | Romano Gary | Chief Medical Officer | A | Common Stock | 108000 | $0.00 | 207,349.0000 | 0 | 108.71% | 0.00% |
| Oct. 1, 2023 | Romano Gary | Chief Medical Officer | A | Employee Stock Option (right to buy) | 36000 | $0.00 | 36,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2023 | GRASSO MARC | Chief Financial Officer | A | Common Stock | 123000 | $0.00 | 155,247.0000 | 0 | 381.43% | 0.00% |
| Oct. 1, 2023 | Kenkare-Mitra Sara | President and Head of R&D | A | Common Stock | 163600 | $0.00 | 341,535.0000 | 0 | 91.94% | 0.00% |
| Oct. 1, 2023 | Kenkare-Mitra Sara | President and Head of R&D | A | Employee Stock Option (right to buy) | 54500 | $0.00 | 54,500.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2023 | Rosenthal Arnon | Chief Executive Officer | A | Common Stock | 397600 | $0.00 | 5,973,423.0000 | 0 | 7.13% | 0.00% |
| Oct. 1, 2023 | Rosenthal Arnon | Chief Executive Officer | A | Employee Stock Option (right to buy) | 132500 | $0.00 | 132,500.0000 | 0 | 9999.99% | 0.00% |
| Sept. 11, 2023 | Polaris Venture Management Co. VI, L.L.C. | TenPercentOwner | S | Common Stock | 500000 | $6.00 | 10,853,817.0000 | 0 | 4.40% | 0.00% |
| Sept. 11, 2023 | MCGUIRE TERRANCE | Director | S | Common Stock | 500000 | $6.00 | 10,948,212.0000 | 0 | 4.37% | 0.00% |
| Sept. 5, 2023 | Rosenthal Arnon | Chief Executive Officer | S | Common Stock | 5647 | $5.19 | 5,575,823.0000 | 0 | 0.10% | 0.00% |
| Sept. 5, 2023 | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 6214 | $5.19 | 177,935.0000 | 0 | 3.37% | 0.00% |
| Sept. 5, 2023 | Romano Gary | Chief Medical Officer | S | Common Stock | 2771 | $5.19 | 99,349.0000 | 0 | 2.71% | 0.00% |
| Sept. 5, 2023 | GRASSO MARC | Chief Financial Officer | S | Common Stock | 1114 | $5.19 | 32,247.0000 | 0 | 3.34% | 0.00% |
| Aug. 22, 2023 | MCGUIRE TERRANCE | Director | J | Common Stock | 13133 | $0.00 | 94,395.0000 | 0 | 16.16% | 0.00% |
| Aug. 22, 2023 | Polaris Venture Management Co. VI, L.L.C. | TenPercentOwner | J | Common Stock | 98533 | $0.00 | 11,353,817.0000 | 0 | 0.86% | 0.00% |
| Aug. 22, 2023 | Polaris Venture Management Co. VI, L.L.C. | TenPercentOwner | J | Common Stock | 500000 | $0.00 | 11,353,817.0000 | 0 | 4.22% | 0.00% |
| Aug. 22, 2023 | Polaris Venture Management Co. VI, L.L.C. | TenPercentOwner | J | Common Stock | 98533 | $0.00 | 11,452,350.0000 | 0 | 0.87% | 0.00% |
| Aug. 22, 2023 | MCGUIRE TERRANCE | Director | J | Common Stock | 500000 | $0.00 | 11,408,813.0000 | 0 | 4.20% | 0.00% |
| Aug. 22, 2023 | MCGUIRE TERRANCE | Director | J | Common Stock | 6429 | $0.00 | 94,395.0000 | 0 | 7.31% | 0.00% |
| Aug. 22, 2023 | MCGUIRE TERRANCE | Director | J | Common Stock | 98533 | $0.00 | 153,549.0000 | 0 | 179.10% | 0.00% |
| Aug. 22, 2023 | MCGUIRE TERRANCE | Director | J | Common Stock | 98533 | $0.00 | 54,996.0000 | 0 | 64.18% | 0.00% |
| June 14, 2023 | GAROFALO ELIZABETH A. | Not found | A | Stock Option (right to buy) | 12360 | $0.00 | 12,360.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | LAVIGNE LOUIS J JR | Not found | A | Common Stock | 26250 | $0.00 | 46,261.0000 | 0 | 131.18% | 0.00% |
| June 14, 2023 | Gerngross Tillman U. | Not found | A | Common Stock | 26250 | $0.00 | 2,644,319.0000 | 0 | 1.00% | 0.00% |
| June 14, 2023 | Gerngross Tillman U. | Not found | A | Stock Option (right to buy) | 12360 | $0.00 | 12,360.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | MCGUIRE TERRANCE | Not found | A | Common Stock | 26250 | $0.00 | 11,928,650.0000 | 0 | 0.22% | 0.00% |
| June 14, 2023 | MCGUIRE TERRANCE | Not found | A | Stock Option (right to buy) | 12360 | $0.00 | 12,360.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Wehner David M. | Not found | A | Common Stock | 26250 | $0.00 | 80,330.0000 | 0 | 48.54% | 0.00% |
| June 14, 2023 | Wehner David M. | Not found | A | Stock Option (right to buy) | 12360 | $0.00 | 12,360.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Yaffe Kristine | Not found | A | Common Stock | 26250 | $0.00 | 35,709.0000 | 0 | 277.51% | 0.00% |
| June 14, 2023 | Yaffe Kristine | Not found | A | Stock Option (right to buy) | 12360 | $0.00 | 12,360.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | LAVIGNE LOUIS J JR | Not found | A | Stock Option (right to buy) | 12360 | $0.00 | 12,360.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | SCHELLER RICHARD H | Not found | A | Common Stock | 26250 | $0.00 | 35,709.0000 | 0 | 277.51% | 0.00% |
| June 14, 2023 | SCHELLER RICHARD H | Not found | A | Stock Option (right to buy) | 12360 | $0.00 | 12,360.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Hammond Paula | Not found | A | Stock Option (right to buy) | 12360 | $0.00 | 12,360.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | GAROFALO ELIZABETH A. | Not found | A | Common Stock | 26250 | $0.00 | 35,709.0000 | 0 | 277.51% | 0.00% |
| June 14, 2023 | Hammond Paula | Not found | A | Common Stock | 26250 | $0.00 | 35,709.0000 | 0 | 277.51% | 0.00% |
| June 2, 2023 | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 4092 | $6.90 | 184,149.0000 | 0 | 2.17% | 0.00% |
| June 2, 2023 | Rosenthal Arnon | Chief Executive Officer | S | Common Stock | 5255 | $6.90 | 5,581,470.0000 | 0 | 0.09% | 0.00% |
| June 2, 2023 | Romano Gary | Chief Medical Officer | S | Common Stock | 2617 | $6.90 | 102,120.0000 | 0 | 2.50% | 0.00% |
| June 2, 2023 | GRASSO MARC | Chief Financial Officer | S | Common Stock | 1050 | $6.90 | 33,361.0000 | 0 | 3.05% | 0.00% |
| March 17, 2023 | Rosenthal Arnon | Chief Executive Officer | S | Common Stock | 15186 | $6.22 | 5,586,725.0000 | 0 | 0.27% | 0.00% |
| March 3, 2023 | Rosenthal Arnon | Chief Executive Officer | A | Common Stock | 42990 | $0.00 | 5,601,911.0000 | 0 | 0.77% | 0.00% |
| Dec. 2, 2022 | Romano Gary | Chief Medical Officer | S | Common Stock | 2145 | $8.71 | 107,975.0000 | 0 | 1.95% | 0.00% |
| March 2, 2023 | Rosenthal Arnon | Chief Executive Officer | S | Common Stock | 5849 | $8.32 | 5,558,921.0000 | 0 | 0.11% | 0.00% |
| March 2, 2023 | GRASSO MARC | Chief Financial Officer | S | Common Stock | 1291 | $8.32 | 34,411.0000 | 0 | 3.62% | 0.00% |
| March 2, 2023 | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 10124 | $8.32 | 188,241.0000 | 0 | 5.10% | 0.00% |
| March 2, 2023 | Romano Gary | Chief Medical Officer | S | Common Stock | 3238 | $8.32 | 104,737.0000 | 0 | 3.00% | 0.00% |
| Sept. 10, 2021 | Yaffe Kristine | Director | M | Common Stock | 2000 | $18.10 | 2,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 10, 2021 | Yaffe Kristine | Director | M | Stock Option (right to buy) | 2000 | $0.00 | 38,000.0000 | 0 | 5.00% | 0.00% |